Skip to main content
. 2021 Sep 14;8(5):769–784. doi: 10.3233/JND-210689

Fig. 1.

Fig. 1

Study Design and Disposition of Patients. *Siblings of previously randomized patients. **Among randomized patients, four received eteplirsen and three had no post baseline NSAA, yielding a full analysis set of 119 patients, 81 in the edasalonexent group and 38 in the placebo group.